ArticleMedComm2025

Triplet Regimen of Metronomic Capecitabine Plus Antiangiogenic Drug and PD-1 Inhibitor as Later-Line Salvage Treatment for Patients With MSS/pMMR Metastatic Colorectal Cancer: A Retrospective Study.

Qiong Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.